Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-050617
Filing Date
2025-04-03
Accepted
2025-04-03 17:29:24
Documents
2
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2266
2 EX-24 phat-ex24.htm EX-24 13330
  Complete submission text file 0000950170-25-050617.txt   17028
Mailing Address 1875 S GRANT STREET SUITE 110 SAN MATEO CA 94402
Business Address
Basta Steven L (Reporting) CIK: 0001417397 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39094 | Film No.: 25811081

Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Issuer) CIK: 0001783183 (see all company filings)

EIN.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)